Determination of human herpes simplex virus in clear cerebrospinal fluids by multiplex polymerase chain reaction (PCR) in Rwanda by Ntagwabira, Edouard et al.
 
African Journal of Biotechnology Vol. 12(19), pp. 2553-2557, 8 May, 2013  
Available online at http://www.academicjournals.org/AJB 
DOI: 10.5897/AJB12.1499 
ISSN 1684-5315 ©2013 Academic Journals  
 
 
 
 
Full Length Research Paper 
 
Determination of human herpes simplex virus in clear 
cerebrospinal fluids by multiplex polymerase chain 
reaction (PCR) in Rwanda 
 
Edouard Ntagwabira1,2*, Dufton Mwaengo1,3, Jean-Frederic Flandin2, Charles Muhizi4, Omu 
Anzala1 and Odette Mukabayire2 
 
1
Department of Medical Microbiology, College of Health Sciences, University of Nairobi, Nairobi, Kenya. 
2
Rwanda Biomedical Center-National Reference Laboratory, Kigali, Rwanda. 
3
Kigali Health Institute, Kigali, Rwanda. 
4
Centre Hospitalier de Butare, Huye, Rwanda. 
 
Accepted 22 June, 2012 
 
The purpose of this study was to test CSF obtained from different regions of Rwanda for herpes 
simplex viruses (HSV) type 1 and 2 using a commercial multiplex PCR kit. CSF samples were 
obtained from patients with clinical suspicion of meningitis and encephalitis which may be caused 
by different microorganisms including herpes viruses. More than 80% of clear cerebrospinal fluid 
(CSF) submitted to two referral hospitals (King Faisal Hospital and University Teaching Hospital of 
Kigali) and to the National Reference Laboratory of Rwanda, were found to be negative for 
Cryptococcus neoformans and Mycobacterium tuberculosis, the only microorganisms tested at 
these facilities.  
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INTRODUCTION 
 
Human herpes viruses, including herpes simplex virus 
type 1 (HSV-1) and type 2 (HSV-2), cytomegalovirus 
(CMV), Epstein-Barr virus (EBV), varicella-zoster virus 
(VZV) and human herpesvirus 6 (HHV-6) commonly 
cause infections of the central nervous system (CNS) 
and the urinary tract. Clinical signs and symptoms 
resulting from these six viruses are often indistinguisha-
ble from other neurological conditions (Baskin and 
Hedlun, 2007). While clinical outcome is favourable when 
therapy is administered in early stages of disease, this 
requires early detection of herpes virus in clinical speci-
mens obtained from the patient. Herpes 
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simplex viruses (HSV) persist in various cells of the 
host following primary infection. Infection of CNS by 
HSV is often associated with severe disease including 
encephalitis and meningitis with recorded mortality 
(Minjolle et al., 2002; Baskin and Hedlun, 2007; Ruzek 
et al., 2007). HSV-1 is the most common cause of 
sporadic encephalitis in adults where the seropreva-
lence is widespread in the population. Meningitis resul-
ting from infection with HSV-2 is usually self-limiting 
and seldom causes severe CNS symptoms (Momméja-
Marin, 2003). As compared to HSV-1 induced encepha-
litis, the symptoms associated with HSV-2 encephalitis 
have been described as milder, often diagnosed as 
meningoencephalitis (Omland et al., 2008). Symptoms 
of HSV-2 CNS infection can arise without typical genital 
herpes eruptions and also in patients who have never 
experienced genital herpes before. 
Encephalitis is an inflammation of the brain, normally 
caused by virus infection (Sindic et al., 2003). In infec-
ted individuals with encephalitis, symptoms such as 
headache, fever, vomiting, confusion and light-sensi-
tiveness are common and can in severe cases also 
cause unconsciousness, seizures and paralysis. Menin- 
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gitis, on the other hand, has bacterial or non-bac-terial 
origin and leads to inflammation of the mem-branes 
covering the brain and spinal cord. Common symptoms 
of meningitis include stiff neck, light-sensitivity, severe 
headache, nausea, fever and mental status changes 
(Sindic et al., 2003). Early specific antiviral therapy will 
significantly reduce the mortality and serious morbidity 
of cases. Since the therapy must be started as possi-
ble, before the patient progresses into more lethal 
forms of the disease, timely diagnosis of HSV infection 
in the CNS must be done for proper treatment. With the 
introduction of PCR, virus DNA can be detected in the 
CSF and is the method most widely used for diagno-
sing viral CNS infections today (DeBiasy et al., 2002). 
In Rwanda, the National Reference Laboratory (NRL) 
and referral hospitals routinely examine clear CSF for 
Cryptococcus neoformans and Mycobacterium tuber-
culosis in patients suspected to have CNS disease. 
However, the majority of clear CSF (more than 80%) 
from clinically suspected cases is negative for these 
infections. The NRL and referral hospitals do not 
examine CSF for HSV infection due to lack of capacity 
to diagnose the virus. The purpose of this study was to 
use a multiplex PCR-based approach to examine the 
presence of HSV-1 and HSV-2 infections in clear CSF 
from people with clinical suspicion of meningitis and 
encephalitis. Results obtained in the study not only give 
the NRL the opportunity to provide leadership to 
Rwanda with respect to HSV diagnostics but also point 
the direction for PCR-based viral diagnostics at NRL for 
any other disease. Furthermore, the implementation of 
multiplex PCR for the detection of HSV will benefit 
Rwandan population and its neighbouring countries as 
treatment with acyclovir is easily available and highly 
effective against these viruses.  
 
 
MATERIALS AND METHODS  
 
A total of 196 participants from three referral and nine district 
hospitals from five provinces in Rwanda were enrolled for this 
study.  
 
 
HSV diagnostics. 
 
DNA from CSF was isolated using Zymo spin (Hartfield, South 
Africa) kit according to manufacturer’s instructions. DNA was 
amplified using Seeplex HSV2 ACE (Seegene, Hartfield, South 
Africa) kit according to manufacturer’s instruction.  PCR was 
carried on a Geneamp 9700 thermocycler and resolved on a 2% 
agarose gel. 
 
 
RESULTS 
 
Multiplex detection of HSV-1 and HSV-2 
 
The expected bands of 300, 473 and 981 bp corres-
ponding to HSV-1, HSV-2 and internal control respec-
tively were observed in both the molecular weight 
markers and positive control samples (Figure 1). Figure 
1 is  a representative gel which shows results for a sec- 
a section of samples that were scored positive for either 
HSV-1 alone (e.g. lanes 6, 7 and 14 (bottom panel)),  
 
 
 
 
HSV-2 alone (lanes 6 to 8, 10 and 12 all on top panel; 
and lanes 9, 10 and 15 on bottom panel), or dually 
infected with HSV-1 and HSV-2 (lane 9 (top panel)). An 
example of a sample in this gel (Figure 1) that had an 
indeterminate result is the sample loaded in well 5 (top 
panel) where a faint HSV-1 band is observed but there 
was no internal control band. This sample was sub-
sequently repeated and found to be positive (data not 
shown). Majority of the samples tested were negative 
for both HSV-1 and HSV-2. Only the internal control 
(981 bp) bands were amplified, indicating that DNA was 
well extracted and PCR reactions were adequate (data 
not shown). 
 
 
Proportion of HSV-1 and HSV-2 as compared to C. 
neoformans and M. tuberculosis in clear CSF 
samples  
 
Data on C. neoformans was obtained from hospitals that 
participated in sampling of clear CSF. In all Rwandan 
hospitals, testing for C. neoformans is routinely done 
using India ink. Culture of these microorganisms on 
SDA media was also performed but only in referral hos-
pitals and at the NRL. M. tuberculosis was done by 
Ziehl-Nelson staining technique. 
A summary of data obtained for C. neoformans from 
different provinces that participated in this study is 
shown in Table 1. Only 11 of 139 clear CSF samples 
(7.9%) from Kigali City Province were positive for C. 
neoformans– samples from all other provinces had no 
C. neoformans. When the entire sample size (196) for 
the study is considered, this translates to only 5.6% of 
samples as C. neoformans positive. For Kigali City 
Province, the prevalence of C. neoformans (7.9%) and 
HSV-1 or HSV-2 (4.3 and 8.6%, respectively) for the 
same population is not statistically different (Figure 2).  
When all samples were analyzed by multiplex PCR, a 
total of 7 samples were positive for HSV-1. Of these, 6 
were from Kigali City Province while one was from 
South Province. The total number of CSF samples from 
these two provinces was 174 (139 from Kigali City and 
35 from South Province). This represented a preva-
lence of 4.0% of HSV-1 for these two provinces alone 
and 3.6% when all the five Rwandan provinces were 
considered (Table 1). On the other hand, 12 out of 38 
CSF samples were positive for HSV-2 alone in Kigali 
City Province, while two samples from Kigali City Pro-
vince were positive for both HSV-1 and HSV-2 (1%). 
This study, therefore, identified a total of 21 out of 196 
CSF samples (10.7%) as being HSV positive. The 
majority of CSF samples were negative for HSV (Table 
1). Of all the clear CSF collected and analyzed, no M. 
tuberculosis infection was detected (data not shown).  
 
 
DISCUSSION 
 
In the present study, both HSV-1 and HSV-2 were de-
tected in clear CSF, indicating that some of the neuro-
logical conditions from individuals where the samples 
were collected could be attributable to HSV, even though 
other viral agents may be responsible. The prevalence
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Figure 1. Multiplex detection of HSV1 and HSV2 in clear CSF. Samples were DNA extracted using Zymo spin (Hartfield, 
South Africa) kit. DNA was amplified using Seeplex HSV2 ACE (Seegene, Hartfield, South Africa) kit according to 
manufacturer’s instruction and resolved on 2% agarose gel and stained using green nucleic acid stain. First two wells 
(top and bottom panel) were loaded with molecular weight markers (M) and with positive control (+ve), respectively. ‘N’ 
designates negative control (top panel). All other wells were loaded with PCR products except for wells 17 and 18 
(bottom panel) which were empty. 
 
 
 
 
 
Figure 2. Summary of the prevalence of C. neoformans and HSV by province. The y-axis shows the 
prevalence of C. neoformans and HSV, while the x-axis shows the provinces within Rwanda where 
clear CSF samples were collected. The bars are shown in color as follows: Blue– proportion of C. 
neoformans (as determined by Indian ink microscopy), red– proportion of HSV-1, green– proportion 
of HSV-2 and purple– proportion of samples with dual infection (both HSV-1 and HSV-2). 
 
 
 
of HSV-1 was much lower than that of HSV-2 (Table 1) 
which is consistent with observations by other groups 
(Chayavichitsilp et al., 2009). Only two individuals were 
dually infected with both viruses from Kigali City 
Province. One observation made in the data (Figure 1) 
is that some bands (for both viruses) were more intense 
than others. Since the test applied here is only a quali-
tative test (that is, to indicate presence or absence of 
HSV DNA), it is likely that band intensity reflected either 
on the abundance of HSV in the sample relative to others
 
2556        Afr. J. Biotechnol. 
 
 
 
Table 1: Comparison of Cryptococcus neoformans and HSV infections by Province 
 
Province 
Cryptococcus neoformans HSV1 HSV2 HSV1/HSV2 coinfections 
Negative Positive Negative Positive Negative Positive Negative Positive 
Number % Number % Number % Number % Number % Number % Number % Number % 
North 7 100.0 0 0.0 7 100.0 0 0.0 7 100.0 0 0.0 7 100.0 0 0.0 
East 7 100.0 0 0.0 7 100.0 0 0.0 7 100.0 0 0.0 7 100.0 0 0.0 
South 35 100.0 0 0.0 34 97.1 1 2.9 35 100.0 0 0.0 35 100.0 0 0.0 
West 8 100.0 0 0.0 8 100.0 0 0.0 8 100.0 0 0.0 8 100.0 0 0.0 
Kigali 128 92.1 11 7.9 133 95.7 6 4.3 127 91.4 12 8.6 137 98.6 2 1.4 
Total 185 94.4 11 5.6 189 96.4 7 3.6 184 93.9 12 6.1 194 99.0 2 1.0 
 
 
 
or different efficiencies of PCR amplification. A quan-
titative assay (such as real-time PCR) will have to be 
applied to determine the relative amounts in different 
CSF samples perhaps in a future study. 
It is well known that CSF
 
may contain inhibitors that 
can partially or completely block
 
DNA polymerase 
activity and cause false negative results. Due
 
to the 
clinical and therapeutic implications of a false-nega-
tive
 
PCR result, identification of inhibited PCRs is a 
priority. Therefore,
 
when PCR is employed for diag-
nostic purposes, it is imperative
 
to adopt adequate 
controls for assessing sample suitability for
 
PCR. In 
the present multiplex PCR assay, occasional false-
negative
 
results for HSV DNA amplification could lead 
to unidentifiable
 
false-negative results if internal 
control primers were not included
 
in the assay. Thus, 
failure of DNA extraction or failure to remove
 
any 
inhibitors of DNA amplification may be avoided by the 
present
 
assay. Apart from the ability to detect two 
different viruses in the same reaction tube, the inclu-
sion of a positive control sample (which is added at 
the stage of setting up PCR in place of CSF-derived 
DNA sample) is important in ensuring specificity of 
amplified HSV DNA from biological samples. Reac-
tions that fulfilled the requirement for positive control 
but had a negative control that failed to either amplify 
the expected internal control band or had more than 
one band were repeated before individual samples 
could be scored as either being positive or negative 
for HSV. 
It is interesting that HSV was detected only in Kigali 
City and South Provinces. Perhaps it is not too 
surprising though, as the majority of CSF samples 
analyzed were from these provinces since of 196 
clear CSF collected, a total of 174 (or 89%) were from 
Kigali City and South Provinces. Since 20 of 21 HSV 
positive CSF were from Kigali City Province alone, the 
prevalence of HSV in this province is 14.3%, a figure 
much higher than the national  average of  10.7% obtained 
in this study. Indeed, all the other 3 provinces had no 
detectable HSV in CSF.  
As shown in Figure 1, HSV detection with multiplex 
PCR from CSF in Rwanda is a major finding. Even 
though there are no laboratories in Rwanda that 
attempt to detect HSV as possible causative agents of 
encephalitis and meningitis, the practice in many 
countries that have not adopted PCR techniques is an 
invasive and expensive brain biopsy specimen proce-
dure which has been previously used as a benchmark 
for the laboratory diagnosis of HSV encephalitis, me- 
ningitis and other CNS diseases.  
The prevalence of C. neoformans was 7.9% out of 
128 samples and 11 (5.6%) out of 196 samples 
collected from five provinces based on data obtained 
from hospitals where clear CSF was collected 
(Desalermos et al., 2012). For patients tested for M. 
tuberculosis, all of them were negative to TB. These 
observations indicate that these microorganisms can 
still be detected in clear CSF, hence the need to 
analyze all clear CSF for C. neoformans infection.  
Routinely, of all CSF samples received by the NRL 
from regional hospitals in Rwanda, only about 20% 
regularly test positive for C. neoformans and/or M. 
tuberculosis. Majority (about 80%) of the CSF sam-
ples were not tested for viruses such as HSV. It is 
quite likely (based on results from this study) that a 
huge fraction of these samples are positive for HSV. 
Since both encephalitis and meningitis are serious 
neurological diseases, it will be important for NRL to 
routinely analyze these samples for HSV; unlike most 
viruses, these can effectively be treated with drugs. 
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